Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NewLink Genetics
Pharma
J&J's Ebola shot excels as part of vaccine combo in trial
Johnson & Johnson and Bavarian Nordic posted positive results in a phase 3 study of their Ebola vaccine combo in Sierra Leone.
Kevin Dunleavy
Sep 14, 2021 9:32am
Merck starts FDA submission for Ebola vaccine
Nov 15, 2018 8:45am
Ebola vaccines from Merck, J&J win BARDA funding
Oct 2, 2017 4:10pm
Merck Ebola shot respose lasts at least a year, study finds
Jun 13, 2017 3:31am
Suit targets NewLink management over failed cancer vaccine trial
May 23, 2017 2:45pm
NewLink grabs up to $76M in Ebola vax assistance
Oct 10, 2016 10:41am
